This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on .
This content is password protected. To view it please enter your password below: Password: The post Protected: Using AI to make a big impact for emerging and mid-sized biopharma companies appeared first on .
This content is password protected. To view it please enter your password below: Password: The post Protected: Customer engagement and pharma’s field force future appeared first on .
Real-world evidence (RWE) is emerging as an important area of research to reveal, in real time, new insights and innovations and is accelerating the development of new and innovative therapies and treatments to improve patient outcomes. An important source of RWE has, until recently, been… Read More »AI, big data and deep real-world evidence – the challenges and opportunities
Previously viewed as a ‘nice to have’ for the pharma industry, virtual trials were already moving from a theoretical to a practical proposition before COVID-19 accelerated their transition. Studies that follow a virtual, decentralised, hybrid or remote model can offer many patient recruitment benefits including… Read More »Virtual trials and the next generation of pharma clinical research
The acute phase of the COVID-19 pandemic tested the UK’s capacity and capability to rapidly deliver crucial clinical research at a time of immense pressure and stress on personnel and resources. It triggered a system-wide response which took the UK’s collaborative culture to new levels.… Read More »Coordinating and delivering research in the pandemic: The UK approach
Anna E. Stevens, CPA, is the Partner-in-Charge of Health Care Services at Weaver, Of the $175 billion in federal Provider Relief Funds (PRF) allocated to healthcare providers, $125 billion has been accepted by hospitals and healthcare providers. The cash infusion was designed to cover costs… Read More »Billions in Federal Provider Relief Funds Have Been Distributed. Now Come Auditing and Compliance.
Shalini Shah, MD is Vice-Chair and Associate Professor, Department of Anesthesiology & Perioperative Care, and Enterprise Director of Pain Services, UC Irvine Health The dominant presence of COVID-19 has not meant the absence of cancer, ear infections, heart attacks, chronic pain, or other illnesses that… Read More »Virtual Engagement During COVID Pushes Paradigm Shift for Physician Training and Patient Care
Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. It can help address well established issues with studies, such as patient recruitment and retention, as… Read More »Increasing patient engagement with UK clinical trials
Join us November 10th to learn how digital engagement can solve challenges for both patients and the brand and learn other benefits that will improve patient experience and address multiple barriers to medication adherence.
Join us October 27th and hear the best practices and new perspectives to help re-engage with your customers during the coronavirus pandemic.
The five new NIHR National Patient Recruitment Centres (NPRCs) are set to shape the future of commercial clinical trials in the UK by offering new ways to conduct late-phase, large-scale research projects. One of the Sector Deal 2 commitments within the Government’s Life Sciences Industrial… Read More »Introducing the new NIHR National Patient Recruitment Centres
In a world jam-packed with COVID-19 information and communications, home health centers are looking for direction. Not only are they adapting to PDGM—the most significant change to Medicare’s payment methodology for home health services in nearly 20 years—but they are also facing strong headwinds from… Read More »Key learnings for the intersection between PDGM and COVID-19 (webinar)